Biotech · Public company · San Diego, CA, US

Belite Bio, Inc

Ticker BLTE · SEC CIK 0001889109

Track this companyFree. Adds Belite Bio, Inc to your Dealase workspace and tells you when its record changes.

Clinical trials42 recruiting or active

Pipeline programs4From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availableNo recent cash burn filed

Pipeline4

A Phase 2/3 Study to Evaluate the Efficacy and Safety of Tinlarebant in Subjects With Stargardt DiseasePHASE2_PHASE3 · ACTIVE_NOT_RECRUITING · started Jul 31, 2024ClinicalTrials.gov NCT06388083 · fetched Nov 12, 2026
Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Geographic AtrophyPHASE3 · ACTIVE_NOT_RECRUITING · started Jul 27, 2023ClinicalTrials.gov NCT05949593 · fetched Nov 12, 2026
Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Adolescent Stargardt DiseasePHASE3 · COMPLETED · started Mar 28, 2022ClinicalTrials.gov NCT05244304 · fetched Nov 12, 2026
Safety and Tolerability of Escalating Doses of BPN-14967 in Healthy AdultsPHASE1 · COMPLETED · started Jul 19, 2019ClinicalTrials.gov NCT04005807 · fetched Nov 12, 2026